osthol has been researched along with Focal Segmental Glomerulosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, YL; Chang, JM; Chao, LK; Chen, A; Chen, HL; Feng-Ling, Y; Hsu, YJ; Hua, KF; Ka, SM; Tsai, CL; Tsai, YJ; Tsai, YL; Wang, YF; Wu, SH; Yang, SM | 1 |
1 other study(ies) available for osthol and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Osthole improves an accelerated focal segmental glomerulosclerosis model in the early stage by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF-κB-mediated COX-2 expression and apoptosis.
Topics: Active Transport, Cell Nucleus; Animals; Antioxidants; Apoptosis; Calcium Channel Blockers; Cnidium; Coumarins; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Female; Glomerulosclerosis, Focal Segmental; Glutathione Peroxidase; Heme Oxygenase-1; Inflammation; Macrophage Activation; Macrophages; Membrane Proteins; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Plant Preparations; Podocytes; Proteinuria; Reactive Oxygen Species | 2014 |